ClinicalTrials.govpublic full text
Gene Correction in Autologous CD34+ Hematopoietic Stem Cells (HbS to HbA) to Treat Severe Sickle Cell Disease
sickle cell disease, sickle cell anemia, gene correction, gene therapy, crispr, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 841368
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.